MYCL promotes the progression of triplenegative breast cancer by activating the JAK/STAT3 pathway. Jiang H, Li X, Wang W, Hu Y, et al. Oncol Rep 2022;48.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang H, Li X, Wang W, Hu Y, et al. MYCL promotes the progression of triplenegative breast cancer by activating the JAK/STAT3 pathway. Oncol Rep 2022;48.
PMID: 36177900